Optimal dosing of fluconazole for treatment of candidemia

被引：0
|
作者：
Elizabeth Dodds Ashley
机构：
来源：
Current Fungal Infection Reports | 2009年 / 3卷 / 2期
关键词：
Minimum Inhibitory Concentration; Candidiasis; Antimicrob Agent; Infectious Disease Society; Candida Parapsilosis;
D O I：
10.1007/s12281-009-0009-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：63 / 65
页数：2
相关论文
共 50 条
  • [31] Economic Analysis of Fluconazole versus Amphotericin B for the Treatment of Candidemia in Non-Neutropenic Patients
    George Dranitsaris
    Peter Phillips
    Coleman Rotstein
    Anitasha Puodziunas
    Steve Shafran
    Gary Garber
    Fiona Smaill
    Irving Salit
    Mark Miller
    Kurt Williams
    John Conly
    Joel Singer
    Steve Ioannou
    PharmacoEconomics, 1998, 13 : 509 - 518
  • [32] Empirical treatment of candidemia in intensive care units: Fluconazole or broad-spectrum antifungal agents?
    Guinea, Jesus
    Pelaez, Teresa
    Rodriguez-Creixems, Marta
    Torres-Narbona, Marta
    Munoz, Patricia
    Alcala, Luis
    Bouza, Emilio
    MEDICAL MYCOLOGY, 2009, 47 (05) : 515 - 520
  • [33] Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
    Gebretekle, Gebremedhin Beedemariam
    Fentie, Atalay Mulu
    Gebremariam, Girma Tekle
    Ali, Eskinder Eshetu
    Erku, Daniel Asfaw
    Alemayehu, Tinsae
    Abebe, Workeabeba
    Sander, Beate
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [34] Economic analysis of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patients
    Dranitsaris, G
    Phillips, P
    Rotstein, C
    Puodziunas, A
    Shafran, S
    Garber, G
    Smaill, F
    Salit, I
    Miller, M
    Williams, K
    Conly, J
    Singer, J
    Ioannou, S
    PHARMACOECONOMICS, 1998, 13 (05) : 509 - 518
  • [35] Fluconazole MIC and the fluconazole dose/MIC ratio correlate with therapeutic response among patients with candidemia
    Clancy, CJ
    Yu, VL
    Morris, AJ
    Snydman, DR
    Nguyen, MH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) : 3171 - 3177
  • [36] The association between fluconazole dose and MIC with mortality and persistence in candidemia
    Nesrin Ghanem-Zoubi
    Majd Qasum
    Johad Khoury
    Danny Zorbavel
    Merav Arnon
    Yuval Geffen
    Mical Paul
    European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 1773 - 1780
  • [37] Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients
    Grau, S.
    Pozo, J. C.
    Roma, E.
    Salavert, M.
    Barrueta, J. A.
    Peral, C.
    Rodriguez, I.
    Rubio-Rodrguez, D.
    Rubio-Terres, C.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 : 527 - 535
  • [38] Impact of fluconazole disk diffusion susceptibility testing on management of Candidemia
    Tantasuwan, S.
    Chongtrakool, P.
    Chayakulkeeree, M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 386 - 386
  • [39] Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients
    Phillips, P
    Shafran, S
    Garber, G
    Rotstein, C
    Smaill, F
    Fong, I
    Salit, I
    Miller, M
    Williams, K
    Conly, JM
    Singer, J
    Ioannou, S
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (05) : 337 - 345
  • [40] The association between fluconazole dose and MIC with mortality and persistence in candidemia
    Ghanem-Zoubi, Nesrin
    Qasum, Majd
    Khoury, Johad
    Zorbavel, Danny
    Arnon, Merav
    Geffen, Yuval
    Paul, Mical
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (09) : 1773 - 1780
12345